{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:24:26Z","timestamp":1793399066562,"version":"4.5.0"},"reference-count":45,"publisher":"Europa Digital & Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.4244\/eijv10i2a35","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T09:51:50Z","timestamp":1405677110000},"page":"212-223","source":"Crossref","is-referenced-by-count":9,"title":["Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial"],"prefix":"10.4244","volume":"10","author":[{"given":"Lisbeth","family":"Antonsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Thayssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik S.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Henrik","family":"Tilsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans E.","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ravkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik T.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Thuesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens F.","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisette O.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-201461418408-0","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.","volume":"356","author":"Kastrati A","year":"2007","journal-title":"N Engl J Med."},{"key":"key-201461418408-1","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.","volume":"356","author":"Stone GW","year":"2007","journal-title":"N Engl J Med."},{"key":"key-201461418408-2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk.","volume":"48","author":"Joner M","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-3","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.jacc.2011.01.023","article-title":"Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularisation.","volume":"57","author":"R\u00e4ber L","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jacc.2011.03.013","article-title":"Second-generation drug-eluting stents. Moving the field forward.","volume":"58","author":"Alfonso F","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jacc.2011.02.022","article-title":"Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial.","volume":"58","author":"Stone GW","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jacc.2011.02.023","article-title":"2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERT\u00c9 stent in all-comers: a randomized open label trial).","volume":"58","author":"Smits PC","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1540-8183.2011.00633.x","article-title":"The real world experience of the everolimus-eluting coronary stent system: audit of everolimus-eluting coronary stents.","volume":"24","author":"Aldous S","year":"2011","journal-title":"J Interv Cardiol."},{"key":"key-201461418408-8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.jacc.2011.06.049","article-title":"Impact of the everolimus-eluting stent on stent thrombosis. A meta-analysis of 13 randomised trials.","volume":"58","author":"Baber U","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents.","volume":"52","author":"Joner M","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1161\/CIRCINTERVENTIONS.111.963256","article-title":"Everolimus-eluting versus sirolimus-eluting stents. A meta-analysis of randomised trials.","volume":"4","author":"De Waha A","year":"2011","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201461418408-11","first-page":"1325","article-title":"Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease.","volume":"58","author":"Byrne RA","year":"2011","journal-title":"3-year outcomes from a randomized clinical trial. J Am Coll Cardiol."},{"key":"key-201461418408-12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jcin.2010.12.005","article-title":"Prospective randomised comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.","volume":"4","author":"Burzotta F","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201461418408-13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jcin.2011.05.024","article-title":"Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions. A randomised LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial.","volume":"4","author":"Park DW","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201461418408-14","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1161\/CIRCULATIONAHA.110.015453","article-title":"Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.","volume":"124","author":"Kim WJ","year":"2011","journal-title":"Circulation."},{"key":"key-201461418408-15","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/j.jacc.2011.07.031","article-title":"Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.","volume":"58","author":"Park KW","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000315136","article-title":"Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v\/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease.","volume":"116","author":"Jensen LO","year":"2010","journal-title":"Cardiology."},{"key":"key-201461418408-17","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","article-title":"Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).","volume":"125","author":"Jensen LO","year":"2012","journal-title":"Circulation."},{"key":"key-201461418408-18","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE","year":"2007","journal-title":"Circulation."},{"key":"key-201461418408-19","first-page":"3741","article-title":"The national patient registry.","volume":"157","author":"Mosbech J","year":"1995","journal-title":"Evaluation of data quality. Ugeskr Laeger."},{"key":"key-201461418408-20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index.","volume":"47","author":"Charlson M","year":"1994","journal-title":"J Clin Epidemiol."},{"key":"key-201461418408-21","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"Epidemiology. When an entire country is a cohort.","volume":"287","author":"Frank L.","year":"2000","journal-title":"Science."},{"key":"key-201461418408-22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.jacc.2008.09.058","article-title":"Two year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry).","volume":"53","author":"Kaltoft A","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.jacc.2007.06.002","article-title":"Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.","volume":"50","author":"Jensen LO","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-24","first-page":"263","article-title":"The Danish National Hospital Register. A valuable source of data for modern health sciences.","volume":"46","author":"Andersen TF","year":"1999","journal-title":"Dan Med Bull."},{"key":"key-201461418408-25","first-page":"354","article-title":"The Danish registers of causes of death.","volume":"46","author":"Juel K","year":"1999","journal-title":"Dan Med Bull."},{"key":"key-201461418408-26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.","volume":"18","author":"Gooley TA","year":"1999","journal-title":"Stat Med."},{"key":"key-201461418408-27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5083\/ejcm.20424884.10","article-title":"Drug-eluting Stents in Acute Coronary Syndrome: Is There a Risk of Stent Thrombosis with Second-Generation Stents?","volume":"1","author":"Chitkara K","year":"2010","journal-title":"Eur J Cardiovasc Med."},{"key":"key-201461418408-28","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1253\/circj.CJ-10-0722","article-title":"Drug-eluting stents are not indicated for patients with acute coronary syndrome \u2013 should drug-eluting stents be indicated for patients with acute coronary syndrome?","volume":"74","author":"Inoue K.","year":"2010","journal-title":"Circ J."},{"key":"key-201461418408-29","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jcin.2011.06.018","article-title":"Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.","volume":"4","author":"Planer D","year":"2011","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201461418408-30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCINTERVENTIONS.108.831800.108.831800","article-title":"Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.","volume":"2","author":"Claessen BE","year":"2009","journal-title":"Circ Cardiovasc Interv."},{"key":"key-201461418408-31","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","article-title":"Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.","volume":"119","author":"Stone GW","year":"2009","journal-title":"Circulation."},{"key":"key-201461418408-32","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.","volume":"299","author":"Stone GW","year":"2008","journal-title":"JAMA."},{"key":"key-201461418408-33","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease.","volume":"362","author":"Stone GW","year":"2010","journal-title":"N Engl J Med."},{"key":"key-201461418408-34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.","volume":"375","author":"Kedhi E","year":"2010","journal-title":"Lancet."},{"key":"key-201461418408-35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcin.2011.11.005","article-title":"Long-term comparison of everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes.","volume":"5","author":"Kalesan B","year":"2010","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201461418408-36","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(11)60395-4","article-title":"Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial.","volume":"377","author":"Silber S","year":"2011","journal-title":"Lancet."},{"key":"key-201461418408-37","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.","volume":"59","author":"von Birgelen C","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-201461418408-38","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.4244\/EIJV7I12A217","article-title":"Everolimus-eluting stents and paclitaxel-eluting stents in patients presenting with myocardial infarction: insights from the two-year results of the COMPARE prospective randomised controlled trial.","volume":"7","author":"Kedhi E","year":"2012","journal-title":"EuroIntervention."},{"key":"key-201461418408-39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.carrev.2011.01.001","article-title":"Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome.","volume":"12","author":"Mahmoudi M","year":"2011","journal-title":"Cardiovasc Revasc Med."},{"key":"key-201461418408-40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jcin.2009.04.003","article-title":"The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.","volume":"2","author":"Kukreja N","year":"2009","journal-title":"JACC Cardiovasc Interv."},{"key":"key-201461418408-41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical pratice: data from a large two-institutional cohort study.","volume":"369","author":"Daemen J","year":"2007","journal-title":"Lancet."},{"key":"key-201461418408-42","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings.","volume":"123","author":"Kolandaivelu K","year":"2011","journal-title":"Circulation."},{"key":"key-201461418408-43","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.","volume":"379","author":"Palmerini T","year":"2012","journal-title":"Lancet."},{"key":"key-201461418408-44","first-page":"1110","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents.","volume":"125","author":"R\u00e4ber L","year":"2012","journal-title":"A prospective cohort study. Circulation."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T09:52:01Z","timestamp":1405677121000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/73th_issue\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["20120425_01"],"URL":"https:\/\/doi.org\/10.4244\/eijv10i2a35","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}